Phoenix, Arizona (UroToday.com) At the meeting titled "The Interval of Fasting, Metabolism, and Cancer Risk," Dr. Marinac on the...


He then discussed the study "Healthy Living and Feeding for Women", a controlled controlled intervention trial with 3,088 breast cancer survivors. Patients were followed longitudinally and measurements were repeated at the beginning of the study for 1 and 4 years. The clinical endpoints studied were breast cancer events (7.3 years follow-up) and mortality (cancer-specific and general).
- Lentings for the night were estimated using diets with timestamps.
- The recurrence of breast cancer was significantly lower in patients with nocturnal fasting> = 13 hours compared to <13 hours
- HR for specific survival of breast cancer (nocturnal fasting> = 13 hours vs. <13 hours): HR 1.21, p = 0.19
- There was also no difference in overall mortality

After a month, they noticed the following results:

Although this is not planned (and this is not explained to the patient as a potential benefit), they found a weight loss of 1 kg in one month regardless of the breed. The average nightly fasting time was 13-13.2 hours, based on 10.6-10.8 hours. There was no difference depending on the breed.
More important:
- 90% said fasting was easy.
- 90% said they could fast for more than 12 hours.
- 70% said they prefer SMS over phone calls.
- 90% found the fast something pleasant
Takeaway Statement: Prolonged fasting at night may be a strategy to reduce cancer risk, as well as excessive morbidity and mortality in cancer survivors.
Presented by: Catherine Marinac, PhD, Dana-Farber Cancer Institute, Boston
Thenappan Chandrasekar, MD, Clinical Instructor, Thomas Jefferson University, twitter: @tchandra_uromd at the 19th Annual Urological Oncology Society (OUA), 28-30 November 2018 - Phoenix, Arizona